Can patient selection and neoadjuvant administration resuscitate PD-1 inhibitors for glioblastoma?

J Neurosurg. 2019 Dec 6;132(5):1667-1672. doi: 10.3171/2019.9.JNS192523. Print 2020 May 1.
No abstract available

Publication types

  • Research Support, N.I.H., Extramural

MeSH terms

  • Brain Neoplasms / drug therapy*
  • Glioblastoma / drug therapy*
  • Humans
  • Immune Checkpoint Inhibitors / therapeutic use*
  • Neoadjuvant Therapy*
  • Patient Selection*

Substances

  • Immune Checkpoint Inhibitors